Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugh J M Brady

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|November 18, 2003
Apoptosis and leukaemiaHugh J M Brady
Immunity|August 20, 2015
ILC Lineage Specification: To Be or Not 11b, That Is the QuestionTomasz Kostrzewski, Hugh J M Brady
European Journal of Immunology|May 10, 2017
Murine thymic NK cells: A case of identityVictoria Male, Hugh J M Brady
Blood Cells, Molecules & Diseases|October 2, 2007
Insights from clinical studies into the role of the MLL gene in infant and childhood leukemiaTanzina Chowdhury, Hugh J M Brady
Current Topics in Microbiology and Immunology|May 23, 2014
Transcriptional control of NK cell differentiation and functionVictoria Male, Hugh J M Brady
Biochemical and Biophysical Research Communications|March 16, 2005
E2F1 up-regulates the expression of the tumour suppressor axin2 both by activation of transcription and by mRNA stabilisationThomas A Hughes, Hugh J M Brady
Cancer Letters|May 12, 2005
Regulation of axin2 expression at the levels of transcription, translation and protein stability in lung and colon cancerThomas A Hughes, Hugh J M Brady
The Journal of Biological Chemistry|December 22, 2004
Expression of axin2 is regulated by the alternative 5'-untranslated regions of its mRNAThomas A Hughes, Hugh J M Brady
Experimental Cell Research|December 2, 2004
Cross-talk between pRb/E2F and Wnt/beta-catenin pathways: E2F1 induces axin2 leading to repression of Wnt signalling and to increased cell deathThomas A Hughes, Hugh J M Brady
Hypertension (Dallas, Tex. : 1979)|May 25, 2005
cMet and Fas receptor interaction inhibits death-inducing signaling complex formation in endothelial cellsLesley Ann Smyth, Hugh J M Brady
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|November 18, 2003
Apoptosis and leukaemiaHugh J M Brady
Immunity|August 20, 2015
ILC Lineage Specification: To Be or Not 11b, That Is the QuestionTomasz Kostrzewski, Hugh J M Brady
European Journal of Immunology|May 10, 2017
Murine thymic NK cells: A case of identityVictoria Male, Hugh J M Brady
Blood Cells, Molecules & Diseases|October 2, 2007
Insights from clinical studies into the role of the MLL gene in infant and childhood leukemiaTanzina Chowdhury, Hugh J M Brady
Current Topics in Microbiology and Immunology|May 23, 2014
Transcriptional control of NK cell differentiation and functionVictoria Male, Hugh J M Brady
Biochemical and Biophysical Research Communications|March 16, 2005
E2F1 up-regulates the expression of the tumour suppressor axin2 both by activation of transcription and by mRNA stabilisationThomas A Hughes, Hugh J M Brady
Cancer Letters|May 12, 2005
Regulation of axin2 expression at the levels of transcription, translation and protein stability in lung and colon cancerThomas A Hughes, Hugh J M Brady
The Journal of Biological Chemistry|December 22, 2004
Expression of axin2 is regulated by the alternative 5'-untranslated regions of its mRNAThomas A Hughes, Hugh J M Brady
Experimental Cell Research|December 2, 2004
Cross-talk between pRb/E2F and Wnt/beta-catenin pathways: E2F1 induces axin2 leading to repression of Wnt signalling and to increased cell deathThomas A Hughes, Hugh J M Brady
Hypertension (Dallas, Tex. : 1979)|May 25, 2005
cMet and Fas receptor interaction inhibits death-inducing signaling complex formation in endothelial cellsLesley Ann Smyth, Hugh J M Brady
Pageof 5